Maternal immunization might protect infants from severe disease due to respiratory syncytial virus (RSV). Guinea pigs are susceptible to infections with RSV and transfer antibodies to their offspring prenatally. Pregnant guinea pigs were immunized by infection with RSV and their offspring were challenged intranasally with RSV. Pulmonary viral replication was compared among the pups born to immunized mothers (group A) and the pups from nonimmune mothers (group B) in two studies. Mean ({SD) log 10 virus titers were, in study 1, group A, 2.3 { 0.8 pfu/g of lung (n Å 10); group B, 3.6 { 1.5 pfu/g (n Å 13) (P Å .0058); and study 2, group A, õ1.69 pfu/g (n Å 8); group B, 3.4 { 0.9 pfu/g (n Å 6) (P Å .0002). Thus, immunization of pregnant guinea pigs resulted in a significant reduction in viral replication in the lungs of their offspring. Guinea pigs should be useful for the study of maternal immunization against RSV.
Respiratory syncytial virus (RSV) is the most common viral
tecture with similarities to that of humans, and there is a prenatal passage of antibodies to the fetus. Antibody uptake postnaagent of lower respiratory tract infections in infancy. No vaccine is available. Challenges to vaccine development include tally by enteric routes is minimal if it occurs [3] . Guinea pigs infected with RSV develop a neutralizing antibody response, the fact that most severe infections occur in infants 2-7 months of age. Studies in animals and in humans have demonstrated and the lungs demonstrate viral replication and histopathologic bronchiolitis [7, 8] . In the work described here, we examined the protective capacity of serum antibodies against RSV [1] . Higher titers of transplacentally acquired antibodies are associthe use of guinea pigs as a model for the study of maternal immunization against RSV infections in young infants. ated with protection against severe disease. Maternal immunization with an immunoaffinity-purified fusion (F) protein of RSV is being investigated in humans. Immunization of pregMethods nant women with the F protein should stimulate the production of neutralizing antibodies, which will raise the titers of antibody
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)143 cells, and the RSV in the infant and contribute to protection against severe RSV strain A2 were grown as described [9] . Mock preparations of uninfected HEp-2 cells were similarly prepared. Virus titers were meainfections [2]. RSV from mother to neonate by the products of lactation [6] .
nized with live RSV intranasally (10 6 pfu in a 100-mL volume),
The guinea pig may provide a useful alternative for studies immunized with a mock preparation, or left unimmunized. Their anesthetized offspring were challenged within 72 h of birth with of maternal immunization. The guinea pig has a placental archithe same amount of live virus intranasally. The pups were anesthetized and killed at 4 days (study 1) or 5 days (study 2) after infection. The right lungs were taken for determination of virus * Mean { SD of pfu/g of lung tissue (log 10 ). Lower limit of detection, 50 pfu or 1.69 log 10 , was used for calculations for lungs with no detectable virus. † ELISA serum antibody titers to RSV from mothers at time of pup challenge and from pups at time of lung harvest are shown as reciprocal titer (log 10 ), mean { SD. Lowest antibody dilution tested by ELISA was 1:30, with õ1.5 log 10 used for samples with no detectable antibody.
‡ Plaque-reduction neutralizing antibody titers are shown as reciprocal of titer in log 2 , with lowest dilution tested, 1:10 (3.3 log 2 ), used for samples with no detectable antibody. Pup samples were pooled and tested as single sample per litter.
were tested in 3-fold dilutions beginning at 1:10. Mean lung titers could replicate in the lungs of neonatal guinea pigs and that and antibody titers were compared using unpaired two-tailed Stupups born to immunized mothers had less viral replication than dent's t tests.
did pups born to naive mothers.
In study 2, we sought to optimize the conditions for infection of the guinea pigs and to determine the reproducibility of the Results observations from study 1. Study 2 differed from study 1 in In study 1, we determined whether neonatal guinea pigs were the following features. The pregnant guinea pigs were immususceptible to infection with RSV and whether immunization nized later in gestation, at 35-45 days. The anesthesia dose of pregnant guinea pigs could modify viral replication in the used for immunization of the pregnant females was increased infected neonate. Pregnant females at 25-35 days of gestation to range from 16 to 35 mg/kg ketamine. The group A females were infected with RSV (group A, 4 females) or were not (3) received live RSV and the group B animals (2) were given inoculated (group B, 3 females). Pups were born 35-40 days a mock immunization intranasally. Pups received an increased after immunization of the mothers. Of the 15 pups born to the amount of anesthesia, with the ketamine component ranging group A females, 10 pups were challenged with RSV (group from 25 to 36 mg/kg. The increased anesthesia resulted in A) and 5 pups received a mock infection (group C; pups from less spontaneous activity among the anesthetized animals. The 3 litters were nursed by a single female). Of the 13 pups born lungs were taken from the pups at 5 days after infection. to the group B females, all were challenged with RSV.
The results of study 2 were similar to those of study 1 (table Some of the anesthetized adult and neonatal animals were 1). The offspring of RSV-immunized females (group A) were noted to have spontaneous activity and swallowing motions.
protected from viral replication in the lungs, and no virus was For the adult animals, we used a dose of ketamine ranging detected in the lungs of these animals ( §98% reduction in from 10 to 13 mg/kg, and for the neonatal animals the doses titers). All but 1 of the offspring of the mock-immunized feranged from 7 to 30 mg/kg. Ketamine doses of 30 to 100 mg/ males (group B) had virus recovered from their lungs. The kg have been given along with xylazine in other studies in higher doses of anesthesia used in study 2 may have allowed guinea pigs [10] . We chose lower drug doses due to concern a greater proportion of the group B pups in study 2 than in about anesthesia in the pregnant female and the lack of informastudy 1 to become productively infected. tion about appropriate dosing of these drugs in neonatal guinea
The kinetics of the antibody response in the immunized pigs. These low doses of ketamine may have resulted in anesfemales in study 2 was evaluated by ELISA. Of the 3 group thesia that was inadequate for some animals and reduced the A mothers, none had antibodies at the time of immunization, amount of the infectious inoculum that reached the lower air-2 had antibodies detected at 8 days, and all 3 had antibodies ways [11, 12] . at 16 days after immunization and at the time of pup challenge Pups born to immunized mothers had a significant (95%) (23-27 days after immunization). The 2 group B mothers in reduction in lung virus titers compared with pups of unimmustudy 2 were tested for antibodies at these same time points nized mothers (study 1, table 1). Three pups in group A and and had no antibodies detected by ELISA. The mean antibody 3 pups in group B had no virus detectable in their lungs at the titers as determined by ELISA for the study 1 and study 2 mothers at the time of pup challenge were very similar to time of harvest. This initial study thus demonstrated that RSV those of the pups at the time of harvest (table 1) . Neutralizing tive mothers acquire detectable cytomegalovirus antibodies prenatally and not via breast milk [15] . It seems likely that antibody titers were also measured for the mothers at the time of pup challenge and the pups at the time of harvest (table 1) .
the majority of the protection demonstrated in this study was transferred prenatally in the form of antibody. The timing (as All of the group A (immunized mothers) pup samples were found to have neutralizing activity. The neutralizing antibody to prenatal or postnatal) of the transfer of protective immunity, and ascertaining whether the protection was in fact mediated titers of the pups in study 1 were almost identical to those of the mothers. The study 2 neutralizing antibody titers were lower by serum antibodies, may be addressed experimentally. Viral replication in the lungs and histopathologic bronchioin the pups than in the mothers but remained within one dilution of the titers of the mothers. The group B (mock or unimmulitis occurs in RSV-infected juvenile guinea pigs [8] . The day of peak viral replication was not reported in the previous studnized) mothers and pups had no detectable antibodies to RSV by ELISA or neutralization.
ies, and we have not yet defined this parameter for the neonatal guinea pigs. We chose 4 and 5 days for harvests on the basis Lung histopathology was evaluated from a limited subset of animals. All had at least some inflammatory changes, including of studies in mice, cotton rats, and ferrets that suggested these days should be near the peak time for viral replication [11, evidence of multifocal interstitial pneumonitis, bronchiolitis, or both. Because of the observation of histopathologic changes 12, 16, 17] . Dose-response characteristics have also not been defined, and the virus dose is a critical determinant of the virus in the mock challenge animals (group C), the mock and viral challenge samples were tested for the presence of endotoxin titers, pathology, and illness seen in a mouse model of RSV infections [11] . We were unable to consistently detect signs of and found to be positive. Because of the effects endotoxin may have on pulmonary tissues [13], we did not attempt further clinical illness among the infected pups.
There are drawbacks to the use of guinea pigs, such as the histopathologic analysis of these samples. It was also possible that the observed changes were due to the presence of HEp-2 fact that the reagents available for the analysis of guinea pig immune responses are not as extensive as those for mice. There cellular components in both the immunizing and challenge virus preparations [14] .
is also relatively little known about antibody transfer from pregnant guinea pigs. However, the guinea pig provides a unique opportunity to explore aspects of the maternal transfer Discussion of immunity using an intact maternal-fetal unit. In addition, the relatively long gestation (Ç63 days) of guinea pigs facilitates Maternal immunization against RSV may offer a means of providing young human infants with protective levels of neuimmunization studies, which require time for the development of the antibody response. The guinea pig should be a useful tralizing antibodies against RSV. The studies reported here demonstrated that neonatal guinea pigs were susceptible to tool for the study of maternal immunization against RSV. pulmonary infection with RSV. In addition, pups born to immune mothers had serum neutralizing antibodies to RSV and Acknowledgments showed significant protection against viral replication in the lungs compared with the pups of nonimmune mothers. These tion against viral replication provided to neonates born to immunized mothers. In both studies, there was a significant reduc-The viral variability of 5 hepatitis C virus (HCV)-infected immunocompromised patients was analyzed and compared with that in isolates from immunocompetent subjects. The patients were followed longitudinally with regard to changes in hypervariable region 1 (HVR1) of HCV using a direct DNA sequencing approach. For the immunocompromised patients, viral nucleotide sequence variability was markedly lower than in immunocompetent HCV-positive patients. For 1 agammaglobulinemic patient and 1 AIDS patient, no variation in the major amino acid sequence of HCV HVR1 could be observed, while another agammaglobulinemic patient exhibited transient variations and amino acid substitutions despite the lack of functioning humoral immune response. The study supports the general hypothesis of humoral immune selection as the main force of sequence variation in the HVR1 region but suggests that other selection mechanisms may contribute to modulation of the composition of the viral population.
Hepatitis C virus (HCV) is the major causative agent of non-
The 27-aa hypervariable region 1 (HVR1) in the N-terminal part of the putative envelope protein of HCV encoded by the A, non-B posttransfusion hepatitis and has a positive singlestranded RNA of Ç9.4 kb with a quasispecies nature [1] . An E2 gene shows a high degree of variation and heterogeneity and appears to contain major neutralizing epitopes [3, 4] . The isolate of hepatitis C is most accurately described as a population of closely related viral variants, for which, in theory, each immune response is generally regarded as the major force driving the selection of new HVR1 variants of HCV [4] [5] [6] . Lack genome can be unique due to the error-prone nature of the viral RNA-directed RNA polymerase. Both positive and negative of variation in HVR1 in the absence of a humoral immune response has been reported by Kumar et al. [7] , but data were selection as well as random sampling events will influence the viral population and the resulting consensus sequence [2] .
limited to 1 patient, and the cloning approach used in the study has drawbacks when the dynamics of HVR1 are to be studied [8, 9] . Antigenic variation in the absence of immune selection
